HIV 1 News and Research

RSS

Opinions: Bachelet appointment; Sanitation MDG; Women's education; Smallholder farms

The appointment of former Chilean President Michelle Bachelet to head U.N. Women is an "excellent choice" that "adds stature and star power to the agenda for gender equality," according to a Los Angeles Times editorial.

18 Sep 2010

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

Archives of Internal Medicine: Associations Between Physician Characteristics And Quality Of Care - Since "most patients do not have access to physician quality measures," they are often encouraged to use public information such as malpractice claims and board certification status to chose a doctor, according to this report that used 2004-2005 insurance claims from about 10,000 Massachusetts physicians for more than 1.13 million adults.

18 Sep 2010

Researchers to develop vaginal microbicide gels to reduce HIV risk

With the support of an $11.8 million, five-year federal grant, researchers at the University of Pittsburgh and their collaborators are developing a quick-dissolving vaginal film containing a powerful drug that reduces the risk of HIV infection, and they plan to begin testing it locally within a year.

17 Sep 2010

Simian immunodeficiency virus is at least 32,000 to 75,000 years old

An ancestor of HIV that infects monkeys is thousands of years older than previously thought, suggesting that HIV, which causes AIDS, is not likely to stop killing humans anytime soon, finds a study by University of Arizona and Tulane University researchers.

17 Sep 2010

Media reporting can reduce impact of infectious disease outbreaks

At the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection. That's the recommendation of two mathematical biologists who have modified the most widely used infectious disease transmission model to account for the impact of news media coverage.

17 Sep 2010

Media outlets examine how maternal health, efforts to reduce global poverty will be central to next week's MDG Summit

Media outlets continued to look ahead to next week's U.N. Millennium Development Goal (MDG) Summit, with a focus on two of the central themes to be addressed at the meeting - maternal health and poverty.

17 Sep 2010

Generex presents Ii-Key hybrids product development at Gene based Vaccines conference

Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.

17 Sep 2010

European Commission approves SmPC update for VIRAMUNE in HIV treatment

Boehringer Ingelheim announced today that the European Commission has approved an update to the Summary of Product Characteristics (SmPC) for VIRAMUNE (nevirapine) in the treatment of patients with HIV.

16 Sep 2010

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today presented promising clinical data for CMX001 in a late-breaker poster session at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.

16 Sep 2010

Maternal mortality worldwide declines by over one-third since 1990, U.N. report says

Maternal mortality has declined by more than one-third since 1990, according to a report from U.N. agencies released on Wednesday, Agence France-Presse reports. But the agencies warned that the rate of progress was too slow and that the decline still misses the maternal mortality Millennium Development Goal target of a three-quarters cut (9/15).

16 Sep 2010

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

K.U.Leuven announced today that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven's compounds with a new mechanism of action for the potential treatment of individuals infected with HIV, the virus that causes AIDS.

16 Sep 2010

New sperm freezing technique may be a boon for IVF

A new improved method of freezing and storing sperm for future use in infertility treatment has arrived as a boon for couples wanting babies.

16 Sep 2010

Maternal mortality decreases by 34%, but 1000 still die a day

The number of women dying due to complications during pregnancy and childbirth has decreased by 34% from an estimated 546 000 in 1990 to 358 000 in 2008, according to a new report, Trends in maternal mortality, released by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Bank.

15 Sep 2010

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.

15 Sep 2010

AIDS activists protest to decry Obama administration's dismal record on AIDS

52 AIDS activists from the groups Housing Works, AIDS Action in Mississippi (AAIM) and AIDS Healthcare Foundation (AHF) interrupted a speech by Health and Human Services Secretary Kathleen Sebelius with a spirited protest to decry the Obama administration's dismal record on AIDS during an appearance by the Secretary at the United States Conference on AIDS (USCA) on Monday in Orlando.

14 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

Gladstone Institute elects for 2010 recipient of Avant-Garde Award for HIV/AIDS Research

The National Institute on Drug Abuse, part of the National Institutes of Health, announced today that Dr. Eric M. Verdin of the J. David Gladstone Institutes in San Francisco, Calif., has been selected as the 2010 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research for his proposal to study the mechanisms of latent HIV infection.

14 Sep 2010

BC-CfE study finds links between insite use, addiction treatment and stopping injection drug use

A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.

14 Sep 2010

Alice Cepeda receives National Award of Excellence in Research for Hispanic drug abuse research

The National Hispanic Science Network on Drug Abuse awarded the National Award of Excellence in Research by a New Investigator to Alice Cepeda, sociology professor and associate director of the Center for Drug and Social Policy Research, Graduate College of Social Work, University of Houston. Cepeda will be honored Sept. 30 at the organization's annual conference in New Orleans.

14 Sep 2010

Excelimmune presents positive results for HRPA therapy against MRSA infections

Excelimmune, Inc. announced positive results from preclinical studies evaluating the efficacy of its human recombinant polyclonal antibody (HRPA) therapy against infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

14 Sep 2010

HIV 1 News and Research

Opinions: Bachelet appointment; Sanitation MDG; Women's education; Smallholder farms

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

Researchers to develop vaginal microbicide gels to reduce HIV risk

Simian immunodeficiency virus is at least 32,000 to 75,000 years old

Media reporting can reduce impact of infectious disease outbreaks

Media outlets examine how maternal health, efforts to reduce global poverty will be central to next week's MDG Summit

Generex presents Ii-Key hybrids product development at Gene based Vaccines conference

European Commission approves SmPC update for VIRAMUNE in HIV treatment

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Maternal mortality worldwide declines by over one-third since 1990, U.N. report says

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

New sperm freezing technique may be a boon for IVF

Maternal mortality decreases by 34%, but 1000 still die a day

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

AIDS activists protest to decry Obama administration's dismal record on AIDS

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gladstone Institute elects for 2010 recipient of Avant-Garde Award for HIV/AIDS Research

BC-CfE study finds links between insite use, addiction treatment and stopping injection drug use

Alice Cepeda receives National Award of Excellence in Research for Hispanic drug abuse research

Excelimmune presents positive results for HRPA therapy against MRSA infections

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News